Sera Prognostics (SERA) Net Equity Issued and Repurchased (2020 - 2025)

Sera Prognostics (SERA) posted Net Equity Issued and Repurchased of $53.6 million for Q1 2025, up 71580.0% on a QoQ basis from -$75000.0 in Q3 2021.

Sera Prognostics (SERA) Net Equity Issued and Repurchased (2020 - 2025) Analysis & Trends

Sera Prognostics' Net Equity Issued and Repurchased history runs 3 years deep, the most recent figure standing at $53.6 million for Q1 2025.

  • Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $53.6 million in Q1 2025, while the trailing twelve-month figure through Dec 2025 was $53.6 million (changed N/A YoY) and the FY2025 annual result came in at $53.6 million, changed N/A from the prior year.
  • Net Equity Issued and Repurchased was $53.6 million for Q1 2025 at Sera Prognostics, up from -$75000.0 in the prior quarter.
  • Across five years, Net Equity Issued and Repurchased topped out at $60.4 million in Q1 2021 and bottomed at -$75000.0 in Q3 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Abbott Laboratories 184.10 Bn 176.81 Bn 6.27 Bn -
2 Stryker 128.79 Bn 125.91 Bn 3.81 Bn -
3 Medtronic 108.97 Bn 99.75 Bn 6.41 Bn 97.00 Mn
4 Boston Scientific 68.57 Bn 67.12 Bn 3.61 Bn -
5 Edwards Lifesciences 47.64 Bn 43.97 Bn 1.29 Bn -
6 GE HealthCare Technologies 28.40 Bn 26.11 Bn 1.98 Bn -
7 Dexcom 28.32 Bn 27.20 Bn 750.30 Mn 12.70 Mn
8 Smith & Nephew 26.94 Bn 26.36 Bn - -
9 Koninklijke Philips 25.45 Bn 22.33 Bn 2.07 Bn -
10 Sera Prognostics 102.28 Mn 102.28 Mn -28,000.00 -

Historic Data

Download Data
DateValue
Mar 31, 2025 53.61 Mn
Mar 31, 2025 53.61 Mn
Sep 30, 2021 -75,000.00
Sep 30, 2021 -75,000.00
Jun 30, 2021 38.64 Mn
Jun 30, 2021 38.64 Mn
Mar 31, 2021 60.42 Mn
Mar 31, 2021 60.42 Mn
Dec 31, 2020 19.60 Mn
Dec 31, 2020 19.60 Mn